Member Info for draft

Lee Cronin who created Deepmatter Ai, a Python based script is saying this is more powerful than Google , and they had thought about calling it HAL after the space odyssey computer. It could out all the big boys half out of business so no wonder AstraZeneca got in quick. deepmatter isn't just code, it will send you emails of your experiments in progress if any issues and you can even view individual molecules moving about. It is speeding up experiments.

Dmtr is like a chemical Google. Their words.

Dmtr ai has the synthesis ai to make a new drug. We know cronin has already recreated 6 of the drugs. Now mish mash them and create the best of the drugs using the best parts we know work.

https://youtu.be/z2vXLfjumlg

Data will be open source and freely available to enable global knowledge sharing and collaboration.

With the COVID-19 pandemic claiming thousands of lives daily, defeating COVID-19 requires a collective effort from everyone working in healthcare and we are committed to playing our part. We continue to pay tribute to those working on the frontlines of this pandemic, in the UK and globally.

AstraZeneca is joining forces with public research bodies and academic institutions as part of a UK government-led initiative to speed up the development of medicines to treat patients hospitalised with COVID-19.

The government-sponsored ACCORD (Accelerating COVID-19 Research & Development) platform is a new, single Phase II clinical trial platform launched in the UK to fast-track research into potential treatments and is part of a co-ordinated therapeutic development pathway that the UK Government has put in place as part of the overall Therapeutics Taskforce.

Funded by the Department of Health and Social Care and UK Research and Innovation, ACCORD has been made possible by partnership working between the Government Scientific Office, the National Institute for Health Research’s Biomedical Research Centres and Clinical Research Facilities, and expert centres in Northern Ireland, Scotland and Wales, clinical research company IQVIA, and AstraZeneca. The ACCORD platform has received rapid regulatory approval and will immediately begin enrolment of COVID-19 patients.

https://www.astrazeneca.com/media-centre/articles/2020/astrazeneca-joins-uk-governments-accord-trial-platform.html

lol im not shouting

Why would they be dreadful lol. They hired a new sales executive. 3 of their clients did good business e.g. opened the Globe Inn. They did cost cutting also. They are in the business of corporate finance.
Your so fearful means this is probably going to go flying up. Furthermore the CEO was previously taken over by Amati before starting up mac. He's a holder of shares here.

The chart looks good and share talk said 2.5p potential. Plus a trading update as usual might be coming

Deep and chemify can come up with a way to make the drugs or tinker with them faster and better and tinkering is what's needed to get the right drug combination to beat this life threatening covid

Just come back when we r 1p

Has about 7% of the shares here . Join the dots

Macs well placed to help hospitality businesses get refinanced

The chemical code to make Remdesivir was produced by @CroninLab a few weeks ago. see on github here: https://t.co/FSOOYoPCOo This will run on our Chemputers. https://t.co/eTXrkMYsLx

Hang on

Screw that

Let's go

Aint not sold any

the MMS dont have shares - similar to what BRH just did - this could do a PYC style rise

sharetalk saying 2.5p is Game on